WHO-GMP certified Semaglutide supplier from India. Generic Ozempic & Wegovy. Injectable and oral formulations. 0.5mg, 1mg, 2mg pens. Licensed importers only. Get price list.
Semaglutide is the active ingredient in Ozempic and Wegovy (Novo Nordisk), and Rybelsus — currently the world's most searched pharmaceutical product. India's WHO-GMP certified generic pharmaceutical industry now produces high-quality generic Semaglutide at a fraction of the branded price, making it accessible to global distributors, licensed pharmacies, and healthcare systems.
NishJay HealthCare India is a certified Semaglutide supplier from India, offering both injectable Semaglutide pens (0.25mg, 0.5mg, 1mg, 2mg) and oral Semaglutide tablets (3mg, 7mg, 14mg) from CDSCO-approved, WHO-GMP certified Indian manufacturers.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for two major indications:
Clinical trials demonstrated that Semaglutide 2.4mg weekly (Wegovy dose) produced an average of 15–17% body weight reduction in adults with obesity — more than any previous anti-obesity medication. This unprecedented efficacy triggered a global supply shortage of branded Ozempic/Wegovy and created massive demand for affordable generic alternatives.
| Parameter | Branded (Ozempic/Wegovy) | Indian Generic |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide (identical) |
| Bioequivalence | Reference product | Bioequivalent |
| Manufacturing standard | WHO-GMP / EU-GMP | WHO-GMP / CDSCO |
| Price (wholesale) | High (branded premium) | 60–85% lower |
| Availability | Shortage in many markets | Available for export |
| Documentation | Full dossier | Full dossier + CoPP |
Equivalent to: Ozempic, Wegovy
Equivalent to: Rybelsus
The global GLP-1 agonist market was valued at USD 23.9 billion in 2023 and is projected to exceed USD 100 billion by 2030. Ozempic alone generated over USD 14 billion in revenue for Novo Nordisk in 2023. The combination of obesity epidemic, Type 2 diabetes prevalence, and strong clinical efficacy data has created extraordinary demand that branded manufacturers cannot fully supply.
This supply gap represents a significant opportunity for licensed importers in the USA, UK, Europe, and Australia to source affordable, quality-assured Indian generic Semaglutide from WHO-GMP certified suppliers like NishJay HealthCare India.
WHO-GMP certified pharmaceutical exporter from Nagpur, India. 4,128+ products. Complete export documentation. 24-hour quotation response.